RYBELSUS

Identification of Rybelsus

No description

Google image searchProduct monograph

Active ingredient

semaglutide, 3 MG

DIN: 02497581

Dosage form(s): TABLET

Route(s) of administration: ORAL

Schedule: Prescription / Schedule D

Company: NOVO NORDISK CANADA INC

Date: 19-APR-2020

ATC:

• A10 — DRUGS USED IN DIABETES (ATC, ATC/DDD, )
• A10B — BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS (ATC, ATC/DDD)
• A10BJ — Glucagon-like peptide-1 (GLP-1) analogues (ATC, ATC/DDD)
• A10BJ06 — SEMAGLUTIDE (ATC/DDD)

Reference brand drug: Ozempic, Rybelsus, Wegovy

Pharmaceutical standard: MFR

External Links for Rybelsus

Search on Google

• Rybelsus side effects
• Rybelsus dosage
• semaglutide side effects
• semaglutide dosage

Novo Nordisk Canada Inc

Go to Novo Nordisk website to see drug product details. Sometimes you can find rybelsus photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.